Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".